Press Releases

Dec 15, 2025 6:00am EST

Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01

Dec 08, 2025 6:00am EST

Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01

Dec 03, 2025 6:00am EST

Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date

Oct 09, 2025 6:00am EDT

Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial

Oct 02, 2025 6:00am EDT

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium

Sep 30, 2025 6:00am EDT

Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial

Sep 18, 2025 6:00am EDT

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland

Sep 10, 2025 6:00am EDT

Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation

Aug 20, 2025 9:25am EDT

Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences

Aug 19, 2025 6:00am EDT

Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team